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1. Introduction 
Transient ischemic attack (TIA) is a common ischemic cerebrovascular disease of neurology and neurosurgery, which was redefined by the 
American Stroke Association in 2009 as: "Transient neu-
rological dysfunction in the brain, spinal cord, and focal 
ischemia of the retina without acute infarction"[1]. In 2011, 
Chinese experts reached a consensus and defined TIA as: 
"Transient neurological dysfunction in the brain, spinal 
cord, or focal ischemia of the retina without acute cerebral 
infarction"[2]. There are about 23.9 million TIA patients 
in China. Moreover, TIA patients' medical treatment rate, 
prevention awareness, recognition rate, diagnosis rate 
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and hospitalization rate are very low. If they do not re-
ceive secondary prevention early, they are highly likely 
to progress to stroke[3]. As the frontier medicine for mid 
to long-term secondary prevention of TIA[4], clopidogrel 
has a good efficacy, low cost and small side effect and 
it is applied widely clinically. Health related quality of 
life (HRQOL) is a comprehensive evaluation of health 
conditions and subjective feelings of the population[5] and 
can be used to observe the condition of TIA patients. In 
this study, we measured the HRQOL score using the short 
form 36 questionnaire (SF-36) scale and analyzed the in-
fluencing factors of HRQOL to provide a reference for the 
treatment effect of clopidogrel. 
2. Data and Methods
2.1 Survey Object
This study includes 168 TIA patients admitted to the De-
partment of Health Management of Daping Hospital of the 
Third Military Medical University from September 2012 
to September 2014. All subjects were investigated before 
admission and after treatment. The study was approved 
by Daping Hospital Ethics Office and informed consent 
forms were signed with the subjects. The diagnosis of TIA 
is based on the criteria set by the American Stroke Associ-
ation in 1990[1]: Repeated attack of transient neurological 
deficits caused by transient ischemic brain damage; the 
typical clinical symptoms would last for no more than 24 
hours; cerebral infarction is excluded by imageological 
examination, and the course of disease is up to 1 year. Ex-
clusion criteria: (1) cerebral infarction and other organic 
nerve injury; (2) non-cerebrovascular disease-induced 
symptoms; (3) patients who cannot participate in the sur-
vey and refuse to receive the questionnaire due to physical 
reasons. A total of 59 subjects who took clopidogrel be-
fore admission are included in the clopidogrel group; 37 
subjects taking aspirin for a long term are included in the 
aspirin group; 72 subjects without secondary prevention 
are included in the untreated group. 
2.2 Survey Method
2.2.1 Survey Tool
 SF-36 scale[6]: It is used to evaluate the life quality, the 
evaluation of the clinical treatment effect and the feedback 
evaluation of health policy in related testing population. 
As a concise health questionnaire, SF-36 includes 36 en-
tries and 8 dimensions, each dimension scoring between 
0-100 and a total score of 800. The higher the score, the 
better the life quality, vice versa. 
2.2.2 Data Collection Method 
SF-36 scale shall be filled by the patient in person and 
collected back immediately; at the same time, the basic 
information of clopidogrel group is recorded, including 
age (< 45, 45-60, ≥ 60), occupation (manual workers, 
mental workers, the unemployed), gender, diet (low-salt 
and low-fat diet refers to sodium intake < 2 g / day, fat 
intake < 50 g / day, cholesterol intake < 300 mg / day), 
history of smoking (defined by lifetime smoking or cumu-
lative smoking for 6 months or longer by WHO), drinking 
(drinking means more than 300 mg of alcohol intake per 
week), exercise (refer to aerobic exercise for more than 
half an hour per day), and education (junior high school 
and below, senior high school and secondary vocation-
al school, junior college and undergraduate, master and 
above), TIA secondary prevention (long-term uninterrupt-
ed administration of anti-platelet drugs, anti-hyperlipid-
emia drugs), body mass index (BMI, ˂ 18.5, 18.5-28, ≥ 
28), with or without hypertension (systolic blood pressure 
≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg), 
with or without diabetes (any blood glucose ≥ 11.1 mmol / 
L, fasting blood glucose ≥ 7.0 mmol / L or OGTT2h blood 
glucose ≥ 11.1 mmol / L), with or without hyperlipidemia 
(fasting serum total cholesterol ≥ 6,145 mmol / L, tri-
glyceride ≥ 1,153 mmol / L), TIA severity score (ABCD2 
score, 0-3 points for low-risk group, 4-5 points for mid-
dle-risk group, 6-7 points for high-risk group), family per 
capita monthly income (< RMB 1,500, RMB 1,500-4,000, 
≥ RMB 4,000), whether the family is harmonious. 
2.3 Statistical Analysis 
SPSS13.0 statistical software is used for statistical analy-
sis, the data are expressed in x ±s, and one-way ANOVA 
is employed for HRQOL score comparison of different 
groups; multivariate stepwise linear regression method 
is used to analyze the influencing factors of clopidogrel 
group's HRQOL score. If P < 0.05, it means the difference 
is of statistical significance. 
3. Results
3.1 HRQOL Score Comparison 
The average HRQOL score of clopidogrel group is 494.15 
± 125.45, the average HRQOL score of aspirin group 
is 491.34 ± 107.33, and the average HRQOL score of 
untreated group is 462.17 ± 97.15. The differences of 
HRQOL scores among three groups are of statistical sig-
nificance (F = 4.29, P = 0.00). Through comparison among 
groups, it is found that there is no difference in HRQOL 
score between clopidogrel group and aspirin group (t = 
5.35, P = 0.00), and HRQOL scores of clopidogrel group 
and aspirin group are higher than those of the untreated 
group (t = 6.14, P = 0.00; t = 5.16, P = 0.00). 
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3.2 General Data Analysis of Clopidogrel Group 
The general data statistics of the clopidogrel group (see 
Table 1) show that the difference of HRQOL score aris-
ing from different age groups, occupations, gender, diet, 
smoking history, drinking history, exercise, BMI, ABCD2 
scores, family harmony are statistically significant (P < 
0.05), and whether the patient is associated with hyper-
tension, diabetes and hyperlipidemia would also cause 
HRQOL score changes (P < 0.05). However, different 
educational level and household income have no impact 
on HRQOL scores (P > 0.05). The higher the ABCD2 
score, the higher the age and the higher the BMI, and the 
lower the HRQOL score. The HRQOL scores of manual 
workers are higher than those of mental workers and the 
unemployed; women's HRQOL scores are lower than 
men's; HRQOL scores of those who have a low-salt and 
low-fat diet are higher than those who don't; the HRQOL 
scores of smokers and alcoholics are relatively low; fami-
ly harmony and regular exercise can significantly improve 
the HRQOL score; concomitant hypertension, diabetes and 
hyperlipidemia will reduce the HRQOL score. (See Table 1)
3.3 Multivariate Stepwise Linear Regression 
Analysis on HRQOL-Related Factors in the 
Clopidogrel Group 
According to the results of one-way ANOVA, statistical-
ly significant variables (excluding education level and 
monthly income) are screened out, and the HRQOL scores 
are assigned as dependent variables using these variables 
as independent variables: Age: (< 45 = 1, 45-60 = 2, ≥ 60 
= 3); Occupation: (Manual worker = 1, mental worker = 2, 
unemployed = 3); Gender: (Male = 1, Female = 2); Diet: 
(Non-low-salt and low-fat diet = 1, low-salt and low-fat 
diet = 2); Smoking condition: (Non-smoking = 1, smoking 
= 2); Drinking condition: (Non-drinking = 1, drinking = 2); 
Exercise: (No exercise = 1, exercise = 2); BMI (˂ 18.5 = 1, 
18.5-28 = 2，≥ 28 = 3); Concomitant hypertension: (No = 1, 
Yes = 2); Concomitant diabetes: (No = 1, Yes = 2); Con-
comitant hyperlipidemia: (No = 1, Yes = 2); ABCD2 score 
(0-3 points = 1, 4-5 points = 2, 6-7 points = 3); Whether 
the family is harmonious (No = 1, Yes = 2). The data are 
analyzed through multivariate stepwise linear regression. 
The results (Table 2) indicate: the HRQOL scores are pos-
itively correlated with diet, exercise, gender and family 
harmony (P < 0.05), but negatively correlated with diabe-
tes, hypertension, smoking, drinking, hyperlipidemia, age, 
career and ABCD2 score (P < 0.05). Five most important 
factors affecting the HRQOL score of the clopidogrel 
group include: diabetes, diet, hypertension, smoking and 
drinking. Multivariate linear regression equation: HRQOL 
= 634.85 - 22.35 × diabetes + 18.34 × diet - 16.20 × hy-
pertension - 15.56 × smoking - 14.37 × drinking (P < 0.05). 
4. Discussion 
TIA is a clinical syndrome characterized by multiple fac-
tors and symptoms and usually presents with transient 
limb stiffness and weakness accompanied by headache, 
dizziness, speech and visual impairment[7]. The current 
prevalence of cardio-cerebrovascular disease in China 
continues to increase, and the incidence of TIA becomes 
more common. TIA is a risk factor for cerebral infarction, 
threatening the patient's health. In essence, TIA and cere-
bral infarction are ischemic brain injury; they are differ-
ent stages of the dynamic process of ischemic lesions, if 
timely prevention and treatment is not in place, TIA has 
a higher probability of conversion to cerebral infarction, 
making disease worse[8]. According to the "Guidelines for 
Secondary Prevention of Ischemic Stroke and Transient 
Ischemic Stroke in China 2010", classical solutions of 
secondary prevention with clopidogrel can significantly 
improve the prognosis of patients with TIA and reduce the 
incidence of cerebral infarction[9]. Clopidogrel is an ADP 
receptor antagonist that blocks platelet activation and in-
hibits platelet aggregation with minimal side effects; and 
it is a frontier medicine for treatment of TIA[10]. However, 
due to the lack of medical knowledge and awareness of 
the risk of TIA, the living habit and living environment of 
TIA patients have a greater impact on the treatment effect 
of clopidogrel. Diagnosis and prognosis of TIA via rou-
tine imaging examination are ineffective; while HRQOL 
employs overall and comprehensive indexes to assess the 
health, which places more emphasis on the roles of in-
dividual and social adaptive capacity in health, and pays 
more attention to individual subjective feelings[11], and 
is particularly suitable for the observation of clopidogrel 
treatment effect. 
This study shows that there are more patients in the 45-
60 years old group, indicating that middle-aged people 
are high incidence group. In terms of occupational factor, 
the higher incidence of mental workers may be related to 
the lack of movement of copywriters. The higher preva-
lence of males than females may be related to the greater 
stress on men's lives. This study shows that the higher the 
ABCD2 score, the lower the HRQOL, showing a negative 
correlation between stroke risk and life quality; there-
fore, more attention should be paid to those with higher 
ABCD2 score. The HRQOL of patients in harmonious 
families is much better, indicating that a good family en-
vironment will help to improve the secondary prevention 
effect of patients treated with clopidogrel. 
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Table 1. General Data Analysis of Clopidogrel Group ( x  ±s) 
Factor Case (proportion) HRQOL score F value P value 
Age 4.08 0.00
˂ 45 12 (18.1%) 513.06±96.34
45-60 35 (53.0%) 489.38±77.84
≥ 60 19 (28.9%) 471.25±64.18
Occupation 3.35 0.00
Manual worker 13 (19.8%) 508.95±82.14
Mental worker 28 (42.4%) 493.25±73.73
Unemployed 58 (37.8%) 478.36±83.22
Gender 4.15 0.00
Male 48 (72.8%) 497.14±65.16
Female 18 (27.2%) 468.01±48.17
Diet 3.93 0.00
Low-salt and low-fat diet 27 (40.9%) 505.77±73.89
Non-low-salt and low-fat diet 39 (59.1%) 475.67±68.31
Smoking history 3.93 0.00
Smoking 21 (31.8%) 468.53±95.14
Non-smoking 45 (68.2%) 499.53±40.05
Drinking history 3.24 0.00
Drinking 19 (28.7%) 468.10±86.35
Non-drinking 47 (71.3%) 493.47±74.16
Exercise 3.57 0.00
Exercise 29 (43.9%) 516.16±93.36
No exercise 37 (56.1%) 465.21±56.32
Educational level 2.31 0.24
Junior high school and below 26 (39.3%) 489.62±74.15
Senior high school and secondary 
vocational school 21 (31.8%) 487.17±97.17
Junior college and undergraduate 12 (18.1%) 479.10±68.14
Master degree and above 7 (10.8%) 492.33±73.17
BMI 3.57 0.00
˂ 18.5 15 (22.7%) 497.32±58.07
18.5-28 18 (27.3%) 484.41±86.71
≥ 28 33 (50.0%) 474.14±61.00
Concomitant hypertension 
Yes 20 (30.3%) 468.56±41.67 3.78 0.00
No 46 (69.7%) 501.35±93.31
Concomitant diabetes 4.26 0.00
Yes 24 (36.3%) 473.15±64.15
No 42 (63.7%) 498.00±90.27
Concomitant hyperlipidemia 3.38 0.00
Yes 18 (27.2%) 463.18±79.62
No 48 (72.8%) 497.37±57.16
ABCD2 score 3.65 0.00
0-3 points 21 (31.8%) 501.35±74.36
4-5 points 29 (43.9%) 483.53±61.24
6-7 points 16 (24.3%) 473.11±90.75
Monthly income 2.09 0.34
< RMB 1500 14 (21.3%) 487.14±77.35
RMB 1500-4000 37 (56.0%) 489.09±65.87
≥ RMB 4000 15 (22.7%) 491.35±89.16
Whether the family is harmonious 4.05 0.00
Yes 49 (74.2%) 506.13±73.43
No 17 (25.8%) 467.64±48.66
20
Journal of Advances in Medicine Science
The results of HRQOL-related factors show that low-
salt and low-fat diet, exercise, gender are positively 
correlated with HRQOL. Low-salt and low-fat diet can 
reduce blood viscosity, thus improving the secondary pre-
vention effect; as a positive factor, exercise has a signifi-
cant effect on the prevention and treatment of TIA, which 
can significantly improve HRQOL. According to the 
suggestions in the "Chinese Guidelines for the Secondary 
Prevention of Ischemic Stroke and Transient Ischemic 
Attack (AHA/ASA 2014 Edition)", TIA patients with the 
capability and the willingness to increase their exercise 
amount shall be recommended to adopt the new and be-
havior-oriented exercise scheme[12]. Clinically, the patients 
should be instructed to increase their exercise and develop 
a low-salt and low-fat diet, upholding healthy life habits. 
Men's HRQOL is significantly better than women, which 
may be related to female hormone endocrine changes and 
higher psychological sensitivity. As negative influencing 
factors, diabetes, hypertension and hyperlipidemia signifi-
cantly reduce the secondary prevention effect of clopido-
grel. AHA/ASA 2014 Guideline suggests patients with TIA 
and metabolic syndrome to receive treatment to lower their 
blood pressure, blood glucose and blood lipid[12]. Therefore, 
while using clopidogrel for secondary prevention, the 
blood pressure, blood glucose and blood lipid shall be 
controlled at normal levels. Smoking and drinking would 
reduce the secondary prevention effect of clopidogrel sig-
nificantly. Nicotine contained in tobacco, tar, and nicotine 
will damage the endothelial cells and cause blood viscosi-
ty, and induce vasospasm, eventually leading to tissue and 
organ ischemia[13]. Long-term uncontrolled drinking can 
also lead to vascular injury and cerebral ischemia exacer-
bation[14]. Medical workers should inform patients of the 
harms of smoking and drinking on heart and cerebral ves-
sels and urge them to quit smoking and drinking. The old-
er the patient is, the worse the HRQOL is, indicating that 
age is also a risk factor for secondary prevention effect of 
clopidogrel. BMI is inversely proportional to HRQOL. As 
a risk factor for cardiovascular and cerebrovascular dis-
eases, obesity reduces the secondary prevention effect of 
clopidogrel. Obese TIA patients shall be educated to low-
er their BMI through diet intervention and exercising. As 
for the occupational factor, the unemployed and mental 
workers lack physical movements and thus have a low-
er HRQOL than the manual workers. During treatment 
of TIA, special attention shall be paid to the mental 
workers and unemployed patients and urge them to ex-
ercise more. 
The results of this study of TIA population HRQOL 
scores are statistically analyzed, showing that the life 
quality of TIA patients taking clopidogrel and aspirin for 
secondary prevention is better than that of the untreated 
group. There are many factors influencing the clopido-
grel's treatment effect. Secondary prevention should be 
carried out with emphasis on the middle-aged and elderly, 
the obese, mental workers and female TIA patients; in the 
meantime, it needs to encourage them to quit smoking and 
drinking and develop the low-salt and low-fat diet, treat 
hypertension, hyperlipidemia and diabetes actively, pay 
attention to psychological counseling and strengthen their 
exercises. All above measures can significantly improve 
the secondary prevention effect of clopidogrel. 
Table 2. Multivariate Linear Stepwise Regression Analysis on HRQOL-Related Factors
Factor Regression coefficient Standard error Standard regression coefficient t value P value 
Constant 634.85 3.15 13.15 0.00
Diabetes -22.35 1.35 -0.33 -4.54 0.00
Diet 18.34 1.31 0.32 4.25 0.00
Hypertension -16.20 1.29 -0.28 -4.13 0.00
Smoking -15.56 1.21 -0.24 -4.04 0.00
Drinking -14.37 1.17 -0.21 -3.89 0.00
Hyperlipidemia -13.79 1.09 -0.19 -3.68 0.01
BMI -12.35 0.99 -0.18 -3.54 0.00
Exercise 11.16 0.87 0.16 3.41 0.00
ABCD2 score -10.85 0.73 -0.14 -3.26 0.00
Age -9.67 0.71 -0.13 -3.07 0.00
Occupation -7.18 0.59 -0.11 -2.74 0.01
Family harmony 5.14 0.52 0.10 2.45 0.00
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